Literature DB >> 20228842

Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells.

M A Matrone1, R A Whipple, K Thompson, E H Cho, M I Vitolo, E M Balzer, J R Yoon, O B Ioffe, K C Tuttle, M Tan, S S Martin.   

Abstract

The cytoskeletal organization of detached and circulating tumor cells (CTCs) is currently not well defined and may provide potential targets for new therapies to limit metastatic tumor spread. In vivo, CTCs reattach in distant tissues by a mechanism that is tubulin-dependent and suppressed by polymerized actin. The cytoskeletal mechanisms that promote reattachment of CTCs match exactly with the mechanisms supporting tubulin microtentacles (McTN), which we have recently identified in detached breast tumor cells. In this study, we aimed to investigate how McTN formation is affected by the microtubule-associated protein, tau, which is expressed in a subset of chemotherapy-resistant breast cancers. We demonstrate that endogenous tau protein localizes to McTNs and is both necessary and sufficient to promote McTN extension in detached breast tumor cells. Tau-induced McTNs increase reattachment of suspended cells and retention of CTCs in lung capillaries. Analysis of patient-matched primary and metastatic tumors reveals that 52% possess tau expression in metastases and 26% display significantly increased tau expression over disease progression. Tau enrichment in metastatic tumors and the ability of tau to promote tumor cell reattachment through McTN formation support a model in which tau-induced microtubule stabilization provides a selective advantage during tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228842      PMCID: PMC3132415          DOI: 10.1038/onc.2010.68

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

Review 1.  Tumor cell adhesion under hydrodynamic conditions of fluid flow.

Authors:  J Haier; G L Nicolson
Journal:  APMIS       Date:  2001-04       Impact factor: 3.205

Review 2.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

Review 3.  Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency.

Authors:  L Weiss
Journal:  Cell Biophys       Date:  1991-04

4.  Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.

Authors:  A Mialhe; L Lafanechère; I Treilleux; N Peloux; C Dumontet; A Brémond; M H Panh; R Payan; J Wehland; R L Margolis; D Job
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 5.  Development of tau aggregation inhibitors for Alzheimer's disease.

Authors:  Bruno Bulic; Marcus Pickhardt; Boris Schmidt; Eva-Maria Mandelkow; Herbert Waldmann; Eckhard Mandelkow
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

6.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

Review 7.  Taxanes, microtubules and chemoresistant breast cancer.

Authors:  Barbara T McGrogan; Breege Gilmartin; Desmond N Carney; Amanda McCann
Journal:  Biochim Biophys Acta       Date:  2007-11-12

8.  Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.

Authors:  L W Engel; N A Young; T S Tralka; M E Lippman; S J O'Brien; M J Joyce
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

9.  Expression of tau protein in non-neuronal cells: microtubule binding and stabilization.

Authors:  G Lee; S L Rook
Journal:  J Cell Sci       Date:  1992-06       Impact factor: 5.285

10.  Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression.

Authors:  Chad A Dickey; Peter Ash; Natalia Klosak; Wing C Lee; Leonard Petrucelli; Michael Hutton; Christopher B Eckman
Journal:  Mol Neurodegener       Date:  2006-07-26       Impact factor: 14.195

View more
  50 in total

Review 1.  Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells.

Authors:  Michael A Matrone; Rebecca A Whipple; Eric M Balzer; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

3.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

4.  Analysis of microtubule growth dynamics arising from altered actin network structure and contractility in breast tumor cells.

Authors:  Eleanor C Ory; Lekhana Bhandary; Amanda E Boggs; Kristi R Chakrabarti; Joshua Parker; Wolfgang Losert; Stuart S Martin
Journal:  Phys Biol       Date:  2017-04-20       Impact factor: 2.583

Review 5.  Molecular Pathways: New Signaling Considerations When Targeting Cytoskeletal Balance to Reduce Tumor Growth.

Authors:  Kristi R Chakrabarti; Lindsay Hessler; Lekhana Bhandary; Stuart S Martin
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

6.  A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles.

Authors:  Kayla J Wolf; Poojan Shukla; Kelsey Springer; Stacey Lee; Jason D Coombes; Caleb J Choy; Samuel J Kenny; Ke Xu; Sanjay Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-07       Impact factor: 11.205

7.  Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.

Authors:  Yaohua Yang; Lang Wu; Xiao-Ou Shu; Qiuyin Cai; Xiang Shu; Bingshan Li; Xingyi Guo; Fei Ye; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Joe Dennis; Irene L Andrulis; Hermann Brenner; Georgia Chenevix-Trench; Daniele Campa; Jose E Castelao; Manuela Gago-Dominguez; Thilo Dörk; Antoinette Hollestelle; Artitaya Lophatananon; Kenneth Muir; Susan L Neuhausen; Håkan Olsson; Dale P Sandler; Jacques Simard; Peter Kraft; Paul D P Pharoah; Douglas F Easton; Wei Zheng; Jirong Long
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

8.  Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin.

Authors:  M I Vitolo; A E Boggs; R A Whipple; J R Yoon; K Thompson; M A Matrone; E H Cho; E M Balzer; S S Martin
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

9.  Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis.

Authors:  Julia A Ju; Cornell J Lee; Keyata N Thompson; Eleanor C Ory; Rachel M Lee; Trevor J Mathias; Stephen J P Pratt; Michele I Vitolo; Christopher M Jewell; Stuart S Martin
Journal:  Lab Chip       Date:  2020-08-03       Impact factor: 6.799

Review 10.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.